Investorideas.com


Be a guest or sponsor our podcasts - learn more about us : 800 665 0411


Share on StockTwits

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; (CSE: BEV) (TSX: FAF) (OTCQB: GBLX) (NASDAQ: NBEV)

 

Delta, Kelowna, BC - December 20, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/122019-StocksToWatch.mp3

Investor Ideas Potcasts, #Cannabis News and #Stocks on the Move; (CSE: BEV) (TSX: FAF) (OTCQB: GBLX) (NASDAQ: NBEV)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few early announcements.

BevCanna Enterprises Inc. (CSE:BEV) (OTC :BVNNF) announced today that it has exercised its option to acquire the right, title and interest to DeeperGreen™, the proprietary water-soluble cannabinoid powder ingredient developed by partner Greener Frontiers.

"DeeperGreen technology expands BevCanna's ability to produce a portfolio of cannabis infused beverage formats," said Emma Andrews, Chief Commercialization Officer at BevCanna. "The addition of a water-soluble powder allows us to offer consumers more variety in methods of consumption, which can now pair with various consumption occasions. Powdered drink mixes complement our existing expertise in ready-to-drink products and allow us to expand the innovation pipeline for our house brands, and with white label partners through contract manufacturing."

DeeperGreen converts extracted cannabis into a fast-acting, tasteless, odorless, water-soluble powdered ingredient, and has been proven to be a stable ingredient that when tested with cannabinoids, consistently delivers target concentrations within one batch and from batch-to-batch. Independent laboratory testing has also confirmed that DeeperGreen precisely infuses granular drink mixes and ready-to-drink water beverages.

Tests have confirmed that DeeperGreen, and products infused with DeeperGreen, meet the criteria to pass the current Cannabis Compliance Regulations set in California, and will allow for reliable water-soluble infusion manufacturing processes and dosing confidence for consumers.

On December 18th, 2019, the Company entered into an amendment agreement to the Cannabis Beverage Joint Development Agreement dated April 1, 2019 with Greener Frontiers Corporation and BevCanna US Operating Company Ltd., a wholly-owned subsidiary of the Company. Pursuant to the Agreement, the Company exercised its right under the JD Agreement to purchase all of the right, title, and interest in and to DeeperGreen and certain other intellectual property assets of Greener Frontiers.

Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Fire & Flower Inc. today announced that it has begun selling new "cannabis 2.0" product formats in its retail stores in the province of Saskatchewan.

The Company is among the first retailers in Canada to be selling these new product formats. This has been achieved through a private wholesale model in the province of Saskatchewan, where the Company's wholly-owned distribution business, Open Fields Distribution purchases from and negotiates prices directly with Licensed Producers.

New product formats in Fire & Flower's assortment will be composed of edibles including gummies, mints and chocolates; and concentrate vaporizers in both all-in-one and cartridge formats. Fire & Flower's initial assortment of cannabis 2.0 products in the province is anticipated to include offerings from the following Licensed Producers and brands prior to the end of 2019: Aphria, Aurora, Dosist, Cronos, The Green Organic Dutchman, High Park, Organigram, Redecan, and Sundial.

"With Fire & Flower being one of the first retailers in Canada to stock new cannabis formats, this exemplifies the clear benefits of the private distribution model including price, access and diversity of product within the province of Saskatchewan," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "We have demonstrated leadership through establishing Open Fields Distribution which supplies both the Fire & Flower retail network and external accounts within the province of Saskatchewan. There is significant demand for these new product formats in the market and we look forward to bringing these products to our loyal customers."

"Our team has worked diligently over the last year and we are thrilled to be launching our Solei, RIFF and Good Supply vaporizers in 510 and all-in-ones at Fire & Flower stores across the province of Saskatchewan," said Bernie Yeung, Vice President, Sales & Channel Strategy with Aphria Inc. "We are confident in our market readiness across the country and look forward to working closely with our retail partners to ensure we have the right brands and product offerings for consumers as we strive to combat the illicit market."

Fire & Flower will continue to monitor consumer preferences of new product formats using the Hifyre digital retail and analytics platform to judiciously manage its product assortment and inventory on-hand.

As new products, including beverages and topcials, become available, Fire & Flower expects to include these products in the Company's assortment, thereby increasing consumer choice of new product formats.

The Company does not yet have a confirmed date for the release of new cannabis product formats in provinces where government-owned provincial distributors control the supply chain.

GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of the National Research Council (NRC) in Halifax, Nova Scotia, CANADA. GB Sciences' PD formulations were able to reduce behavioral changes associated with the loss of dopamine-producing neurons, which underlies the pathology of Parkinson's disease in the animal model. Our final phase of testing will study the mechanism of action for these promising formulations, which could potentially help patients with this debilitating disease. The combined direct and indirect costs associated with Parkinson's disease are estimated at $52 billion in the U.S. alone.

"Several of GB Sciences' mixtures were effective. In fact, our most effective mixture was able to 'rescue' the PD-like behavioral changes to the point where the treated animal's behavior was back to baseline. In addition, our PD formulas produced negligible side effects, which is equally important," explained Dr. Andrea Small-Howard, Chief Science Officer and Director of both GB Sciences, Inc. and GBS Global Biopharma, Inc. "These important preclinical results will be included as 'proof of concept' in GB Sciences' Investigational New Drug application with the US FDA in order to enter into our 'First-in-Man' human clinical trial as early as next year."

Central to the development of Parkinson's disease is the loss of dopamine-producing neurons. Reduced dopamine levels in the brain lead to movement disorders. GB Sciences' PD formulations may be protecting dopamine-producing neurons, or they may cause the surviving neurons to produce more dopamine to compensate for a loss in the number of dopamine-producing neurons. The final phase of GB Sciences' preclinical study will examine these and other possible mechanisms for their effectiveness.

"These positive preclinical results suggest that our cannabinoid-containing complex mixtures may be useful for the treatment of Parkinson's disease symptomology," said Dr. Michael Farley, President and Director of GBS Global Biopharma, Inc.. "We look forward to bringing these promising formulations into human clinical trials as early as 2020."

New Age Beverages Corporation (NASDAQ: NBEV), the Colorado-based healthy products company, announced the launch of its hemp portfolio in Australia and New Zealand.

Under the umbrella of its Health Sciences Division, NewAge received approval and has begun selling its premium portfolio of hemp oils, creams and lotions in Australia and New Zealand. The launch initially features three distinct products:

  1. 'NHANCED Hemp Body Cream in a 120 mL tub
  2. 'NHANCED Hemp Roll-On Gel 90 mL roll-on
  3. 'NHANCED Hemp Oil containing 30 mL tincture

The products will be sold immediately through more than 2,000 direct-to-consumer distribution partners across Australia and New Zealand.

"'NHANCED Hemp is proving to be one of our most talked about product lines we have launched," said Brent Willis, Chief Executive Officer of NewAge. "Receiving approval and beginning to sell our products in these markets further puts us on the right path to become a leading player in the hemp/CBD industry in Australia and New Zealand."

NewAge's research and development teams and scientists worked exhaustively over the past year to develop the hemp specific formulas that both meet the regulatory requirements of markets like Australia and New Zealand but also maintained the efficacy, strength, and benefit of NewAge's full strength CBD formulas.

"'NHANCED Hemp products were designed and developed to meet stringent government hemp (cannabis sativa) and cannabidiol (CBD) regulations for safety, purity and efficacy," said Laura Kimball, director of product development. "The hemp in these three products is sourced from industrial hemp grown in the USA and the mature seed is then carefully processed to ensure that it is pure and completely free from tetrahydrocannabinol (THC)."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure:Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info:https://www.investorideas.com/About/Disclaimer.aspLearn more about publishing your news release and our other news services on the Investorideas.com newswirehttps://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories